aripiprazole 2 mg oral tablet
1 INDICATIONS AND USAGE Aripiprazole is an atypical antipsychotic. The oral formulation is indicated for: Schizophrenia ( 14.1 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette's disorder ( 14.5 ) Aripiprazole tablets are indicated for the treatment of Schizophrenia Irritability Associated with Autistic Disorder Treatment of Tourette's Disorder
zydus pharmaceuticals (usa) inc.
OVAL WHITE L1
L1 OVAL WHITE
Related Pills
Meclizine Hydrochloride 25 MG Oral Tablet
Life Line Home Care Services, Inc.
MECLIZINE HYDROCHLORIDE Meclizine Hydrochloride 25 MG Oral Tablet
REMEDYREPACK INC.
maximum strength Famotidine 20 MG Oral Tablet
Publix Super Markets Inc
maximum strength Famotidine 20 MG Oral Tablet
Publix Super Markets Inc
acid controller original strength famotidine tablet
cvs pharmacy
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 HowSupplied
ARIPIPRAZOLE Tablets, 2 mg are white to off-white, capsule-shaped, uncoated tablets debossed with 'L1' on one side and plain on the other side and are supplied as follows: NDC 68382-439-06 in bottle of 30 tablets with child-resistant closure. NDC 68382-439-01 in bottle of 100 tablets with child-resistant closure. NDC 68382-439-05 in bottle of 500 tablets NDC 68382-439-77 in cartons of 100 tablets (10 x 10 unit-dose)
ARIPIPRAZOLE Tablets, 5 mg are white to off-white, barrel-shaped, uncoated tablets debossed with 'ZE 13' on one side and plain on other side and are supplied as follows: NDC 68382-082-06 in bottle of 30 tablets with child-resistant closure. NDC 68382-082-01 in bottle of 100 tablets with child-resistant closure.
ARIPIPRAZOLE Tablets, 10 mg are white to off-white, capsule-shaped, uncoated tablets debossed with 'ZE 4' on one side and plain on the other side and are supplied as follows: NDC 68382-083-06 in bottle of 30 tablets with child-resistant closure. NDC 68382-083-14 in bottle of 60 tablets with child-resistant closure. NDC 68382-083-16 in bottle of 90 tablets with child-resistant closure. NDC 68382-083-19 in bottle of 120 tablets with child-resistant closure. NDC 68382-083-10 in bottle of 1,000 tablets
ARIPIPRAZOLE Tablets, 15 mg are white to off-white, round-shaped, biconvex, uncoated tablets debossed with 'ZE 14' on one side and plain on other side and are supplied as follows: NDC 68382-084-06 in bottle of 30 tablets with child-resistant closure NDC 68382-084-14 in bottle of 60 tablets with child-resistant closure. NDC 68382-084-16 in bottle of 90 tablets with child-resistant closure. NDC 68382-084-19 in bottle of 120 tablets with child-resistant closure. NDC 68382-084-10 in bottle of 1,000 tablets
ARIPIPRAZOLE Tablets, 20 mg are white to off-white, barrel-shaped, uncoated tablets debossed with 'ZE 15' on one side and plain on the other side and are supplied as follows: NDC 68382-085-06 in bottle of 30 tablets with child-resistant closure. NDC 68382-085-14 in bottle of 60 tablets with child-resistant closure. NDC 68382-085-16 in bottle of 90 tablets with child-resistant closure NDC 68382-085-19 in bottle of 120 tablets with child-resistant closure. NDC 68382-085-10 in bottle of 1,000 tablets
ARIPIPRAZOLE Tablets, 30 mg are white to off-white, round-shaped, biconvex, uncoated tablets debossed with 'ZE 16' on one side and plain on other side and are supplied as follows: NDC 68382-086-06 in bottle of 30 tablets with child-resistant closure. NDC 68382-086-14 in bottle of 60 tablets with child-resistant closure. NDC 68382-086-16 in bottle of 90 tablets with child-resistant closure. NDC 68382-086-19 in bottle of 120 tablets with child-resistant closure. NDC 68382-086-10 in bottle of 1,000 tablets 16.2 Storage Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight container.
More pills like OVAL L1